HOME >> BIOLOGY >> NEWS
JCI table of contents: June 14, 2007

EDITOR'S PICK

Hot on the TRAIL of controlling inflammation in bacterial meningitis

In a study appearing online on June 14 in advance of publication in the July print issue of the Journal of Clinical Investigation, researchers at Charite Universitatsmedizin Berlin report that the molecule known as TRAIL can limit excessive immune responses in bacterial meningitis and as such may be of use to control inflammation of the spinal cord and brain, which causes brain cell death in this life-threatening disease.

Pneumococcal meningitis involves inflammation of the protective membranes covering the brain and spinal cord and is caused by infection with the bacterium Streptococcus pneumoniae. The observed swelling of the brain is largely the result of the excessive immune response to infection. The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been previously reported to play a role in the regulation of the host immune response. In the current study, Joerg Weber and colleagues administered components of Streptococcus pneumoniae bacteria to the cerebrospinal fluid bathing the brain and spinal cord of mice lacking TRAIL. They found that these animals suffered from increased inflammation and brain cell death, however these effects were reversed by the administration of recombinant TRAIL (rTRAIL). Importantly, the application of rTRAIL to mice with intact TRAIL and meningitis also decreased inflammation and neuronal cell death. Finally, the authors observed that human patients with bacterial meningitis showed increased synthesis in the cerebrospinal fluid of TRAIL. The results of the study provide evidence that TRAIL acts to limit inflammation of the brain and spinal cord during bacterial meningitis, suggesting that it may be of use as an anti-inflammatory agent in invasive bacterial infections.

TITLE: TRAIL limits excessive host immune responses in bacterial meningitis

AUTHOR CONTACT:
Joerg W
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
14-Jun-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2019)... ... July 25, 2019 , ... ... first mixed reality headsets to include a new generation eye tracker with hassle-free ... in Los Angeles, California (July 30 - August 1). SIGGRAPH attendees will be ...
(Date:7/23/2019)... ... , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical trial, expected ... knee. , This is the first of several planned clinical trials which ...
(Date:7/19/2019)... ... ... VetStem Biopharma has long been a leader in veterinary stem cell ... two-year research collaboration with Calidi Biotherapeutics, VetStem has signed a worldwide license and development ... be able to fast-track this cancer therapy for use in dogs due to the ...
Breaking Biology News(10 mins):
(Date:8/14/2019)... Texas (PRWEB) , ... August 13, 2019 , ... ... Collins, Colorado to focus on prepackaged mobile phases for QC laboratories. After gaining ... Chata from its laboratory sciences approach into a valued supplier of manufacturing processing ...
(Date:8/6/2019)... ... August 05, 2019 , ... Advanced Clinical, a clinical ... distinguished leader by PharmaVOICE magazine, earning him a prestigious spot on the 2019 ... special issue. , As the executive vice president of business development and marketing ...
(Date:7/23/2019)... ... July 22, 2019 , ... ... best-in-class services in the fields of 3D tissue imaging , digital ... Visikol initially started back in 2013 as a products company. These products are ...
(Date:7/17/2019)... (PRWEB) , ... July 16, 2019 , ... ... according to a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers ... in Kalorama Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics . ...
Breaking Biology Technology:
Cached News: